What’s Next for Cannabis in 2022-Part 1

What’s Next for Cannabis in 2022-Part 1

What’s Next for Cannabis in 2022-Part 1: New Disruptors in Cannabis: The Rise of Psychedelics and New Cannabinoids. Studies of MDMA, ketamine, psilocybin mushrooms, and other psychedelics have shown tremendous potential for therapeutic applications. In May 2021, Nature Medicine published the results of the most advanced trial of psychedelic therapy to date. In our Phase 3 trial of MDMA-assisted therapy for PTSD, 88% of participants who received MDMA in conjunction with trauma-focused therapy experienced a clinically significant reduction in symptoms; 67% of participants no longer met the criteria for a PTSD diagnosis. Many participants reported MDMA-assisted therapy helped them address the root cause of their trauma for the first time. Using a process his lab developed in 2015, Chang Lu, the Fred W. Bull Professor of Chemical Engineering in the College of Engineering, is helping his Virginia Commonwealth University collaborators study the epigenomic effects of psychedelics. Their findings give insight into how psychedelic substances like psilocybin, mescaline, LSD, and similar drugs may relieve symptoms of addiction, anxiety, depression, and post-traumatic stress disorder. The drugs appear to work faster and last longer than current medications — all with fewer side effects.

What's
New cannabis-derived compounds coming to market in 2022: Delta 10 products, THC-O products, and HHC products. Cannabis companies do possess an advantage over other companies that are trying to adopt blockchain and have strong traceability requirements. As the legal cannabis industry is very new, cannabis companies are quite modern, and therefore more equipped to integrate a solution like a blockchain easily into their workflow. These are typically young companies with a strong growth culture and generally have less complicated supply chains/structures. Cannabis 2.0 is a source of great hope for the industry, as it can include ingredients from many vendors and combine them into one product. The concept of blockchain where Cannabis 2.0 is concerned makes even more sense, as the ability to trace the history for each product that has obviously gone through a few processes would really increase consumer trust.